Abiopharma

Regen Biopharma, Inc. (RGBPP)

SEC News
Jan. 13, 2026, 11:03 UTC
8
0 comments

New Form QUALIF - Regen BioPharma Inc Filed: 2026-01-12 AccNo: 9999999994-26-000013 Size: 1 KB

Comment Full text

MITESCO, INC. (MITI)

SEC News
Jan. 13, 2026, 11:03 UTC
8
0 comments

New Form 424B3 - Mitesco, Inc. Filed: 2026-01-13 AccNo: 0001185185-26-000117 Size: 1 MB

Comment Full text

Dynatronics Corp. (DYNT)

Technical Exchange News
Jan. 13, 2026, 10:42 UTC
7
0 comments

Grey symbol attribute type Security_Name was changed. Previous value: CLIENTELE LTD. New value: DYNATRONICS CORP.

Comment Full text

HC Surgical Specialists Limited (1B1)

SEC News
Jan. 13, 2026, 09:44 UTC
9
0 comments

Mandatory Cash Dividend/ Distribution:

Comment Full text

HC Surgical Specialists Limited (1B1)

SEC News
Jan. 13, 2026, 09:40 UTC
9
0 comments

General Announcement: Press release

Comment Full text

HC Surgical Specialists Limited (1B1)

SEC News
Jan. 13, 2026, 09:38 UTC
8
0 comments

Financial Statements and Related Announcement: Half Yearly Results

Comment Full text

FDA approves FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE from RESPIRENT PHARMS

FDA Approval
Jan. 13, 2026, 09:37 UTC
27
0 comments

Final approval of ANDA #ANDA #214464 for FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE. Decision date: 01/12/2026

Comment Full text

FDA updates labeling for METHYLPHENIDATE HYDROCHLORIDE

FDA Approval
Jan. 13, 2026, 09:37 UTC
27
0 comments

Labeling changes approved for ABHAI LLC. Active ingredient: METHYLPHENIDATE HYDROCHLORIDE. Decision date: 01/09/2026

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

FDA Approval
Jan. 13, 2026, 09:37 UTC
29
0 comments

Labeling changes approved for VISTAPHARM LLC. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 01/06/2026

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

FDA Approval
Jan. 13, 2026, 09:37 UTC
24
0 comments

Labeling changes approved for HIKMA. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 01/06/2026

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

FDA Approval
Jan. 13, 2026, 09:37 UTC
26
0 comments

Labeling changes approved for NOVEL LABS INC. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 01/06/2026

Comment Full text

FDA approves SUCRALFATE from GLENMARK PHARMS LTD

FDA Approval
Jan. 13, 2026, 09:37 UTC
22
0 comments

Final approval of ANDA #ANDA #212141 for SUCRALFATE. Decision date: 01/05/2026

Comment Full text

Mind Medicine (MNMD)

Technical Exchange News
Jan. 13, 2026, 08:57 UTC
9
0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Mind Medicine (MindMed) Inc. - Common Shares. New value: Denium Therapeutics, Inc - Common Shares.

Comment Full text

iRhythm Technologies Inc (IRTC)

Technical Exchange News
Jan. 13, 2026, 08:57 UTC
10
0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: iRhythm Technologies, Inc. - Common Stock. New value: iRhythm Holdings, Inc. - Common Stock.

Abiopharma

Regen Biopharma, Inc. (RGBPP)

MITESCO, INC. (MITI)

Dynatronics Corp. (DYNT)

HC Surgical Specialists Limited (1B1)

HC Surgical Specialists Limited (1B1)

HC Surgical Specialists Limited (1B1)

FDA approves FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE from RESPIRENT PHARMS

FDA updates labeling for METHYLPHENIDATE HYDROCHLORIDE

FDA updates labeling for OXYCODONE HYDROCHLORIDE

FDA updates labeling for OXYCODONE HYDROCHLORIDE

FDA updates labeling for OXYCODONE HYDROCHLORIDE

FDA approves SUCRALFATE from GLENMARK PHARMS LTD

Mind Medicine (MNMD)

iRhythm Technologies Inc (IRTC)

Mesoblast Limited (MESO)

Search

News categories

News list

Search

News categories